OBJECTIVE: This study evaluated closed-loop insulin delivery with a model predictive control (MPC) algorithm during early (12-16 weeks) and late gestation (28-32 weeks) in pregnant women with type 1 diabetes. RESEARCH DESIGN AND METHODS: Ten women with type 1 diabetes (age 31 years, diabetes duration 19 years, BMI 24.1 kg/m(2), booking A1C 6.9%) were studied over 24 h during early (14.8 weeks) and late pregnancy (28.0 weeks). A nurse adjusted the basal insulin infusion rate from continuous glucose measurements (CGM), fed into the MPC algorithm every 15 min. Mean glucose and time spent in target (63-140 mg/dL), hyperglycemic (>140 to ≥ 180 mg/dL), and hypoglycemic (140 mg/dL) was 7% (0-40%) in early and 0% (0-6%) in late pregnancy (P = 0.25)...
In patients with type 1 diabetes who are not pregnant, closed-loop (automated) insulin delivery can ...
Achieving tight glucose control safely in type 1 diabetes with currently available methods of insuli...
Background Pregnant women with type 1 diabetes strive for tight glucose targets (3.5-7.8 mmol/L) to ...
OBJECTIVE - This study evaluated closed-loop insulin delivery with a model predictive control (MPC) ...
OBJECTIVE: This study evaluated closed-loop insulin delivery with a model predictive control (MPC) a...
BACKGROUND In patients with type 1 diabetes who are not pregnant, closed-loop (automated) insulin de...
BACKGROUND: In patients with type 1 diabetes who are not pregnant, closed-loop (automated) insulin d...
OBJECTIVE: Despite advances in technology, optimal glucose control remains elusive and neonatal comp...
OBJECTIVE: To evaluate the safety and efficacy of closed-loop insulin delivery in well-controlled pr...
OBJECTIVE: To evaluate the safety and efficacy of closed-loop insulin delivery in well-controlled pr...
OBJECTIVE This study aimed to evaluate the efficacy of closed-loop insulin delivery postpartum. RESE...
OBJECTIVEdTo evaluate the safety and efficacy of closed-loop insulin delivery in well-controlled pre...
BACKGROUND Hybrid closed-loop insulin therapy has shown promise for management of type 1 diabetes d...
Background: Outside pregnancy, closed-loop (automated) insulin delivery can improve glycemic control...
BACKGROUND In patients with type 1 diabetes who are not pregnant, closed-loop (automated) insulin de...
In patients with type 1 diabetes who are not pregnant, closed-loop (automated) insulin delivery can ...
Achieving tight glucose control safely in type 1 diabetes with currently available methods of insuli...
Background Pregnant women with type 1 diabetes strive for tight glucose targets (3.5-7.8 mmol/L) to ...
OBJECTIVE - This study evaluated closed-loop insulin delivery with a model predictive control (MPC) ...
OBJECTIVE: This study evaluated closed-loop insulin delivery with a model predictive control (MPC) a...
BACKGROUND In patients with type 1 diabetes who are not pregnant, closed-loop (automated) insulin de...
BACKGROUND: In patients with type 1 diabetes who are not pregnant, closed-loop (automated) insulin d...
OBJECTIVE: Despite advances in technology, optimal glucose control remains elusive and neonatal comp...
OBJECTIVE: To evaluate the safety and efficacy of closed-loop insulin delivery in well-controlled pr...
OBJECTIVE: To evaluate the safety and efficacy of closed-loop insulin delivery in well-controlled pr...
OBJECTIVE This study aimed to evaluate the efficacy of closed-loop insulin delivery postpartum. RESE...
OBJECTIVEdTo evaluate the safety and efficacy of closed-loop insulin delivery in well-controlled pre...
BACKGROUND Hybrid closed-loop insulin therapy has shown promise for management of type 1 diabetes d...
Background: Outside pregnancy, closed-loop (automated) insulin delivery can improve glycemic control...
BACKGROUND In patients with type 1 diabetes who are not pregnant, closed-loop (automated) insulin de...
In patients with type 1 diabetes who are not pregnant, closed-loop (automated) insulin delivery can ...
Achieving tight glucose control safely in type 1 diabetes with currently available methods of insuli...
Background Pregnant women with type 1 diabetes strive for tight glucose targets (3.5-7.8 mmol/L) to ...